Free Republic

Johnson & Johnson's COVID-19 has had positive results in South Africa, the co-head of a trial, Glenda Gray, told reporters Friday. A research study conducted from mid-February to May with upwards of 470,000 health workers showed positive results in those inoculated, and the country’s health regulator approved the single-shot J&J vaccine in Apri. It is being used in addition to Pfizer's. The study showed 91% to 96.2% protection against death, Gray said, and 67% efficacy against infection when the beta coronavirus dominated and 71% when the delta variant did. As of Thursday, more than 8.3 million people had been vaccinated...

The Food and Drug Administration is preparing to announce a new warning for the Johnson & Johnson coronavirus vaccine saying the shot has been linked to a serious but rare side effect called Guillain-Barré syndrome, in which the immune system attacks the nerves, according to four individuals familiar with the situation. About 100 preliminary reports of Guillain-Barré have been detected in vaccine recipients after the administration of 12.8 million doses of Johnson & Johnson vaccine in the United States, the Centers for Disease Control and Prevention said in a statement Monday. The cases have largely been reported about two weeks...